ASO Therapy

AcuraStem Secures $1M Award to Advance AS-241 for ALS

Pasadena, California, USA, October 27, 2026 AcuraStem, a biotechnology company developing treatments for neurodegenerative diseases, has received a US$1...

By cGxPwire Editor
October 30, 2026

Bio-Pharma

AusperBio Raises $120M to Advance Next-Gen HBV Therapies

SAN FRANCISCO, Aug 27, 2026 AusperBio Therapeutics has completed a $120 million Series C financing to accelerate the development...

By cGxPwire Editor
August 28, 2026

MedTech

Waters Strengthens Clinical Diagnostics with Xevo XR Innovation

MILFORD, Mass., July 27, 2026 Waters Corporation has introduced the Xevo™ TQ Absolute XR IVD Mass Spectrometer, expanding its...

By cGxPwire Editor
July 28, 2026

Bio-Pharma

BioMarin Partners n-Lorem on First ReNU Syndrome Therapy

SAN RAFAEL, Calif. & SAN DIEGO, July 27, 2026 BioMarin Pharmaceutical Inc. and the n-Lorem Foundation have announced a...

By cGxPwire Editor
July 28, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

AcuraStem Secures $1M Award to Advance AS-241 for ALS

AusperBio Raises $120M to Advance Next-Gen HBV Therapies

Waters Strengthens Clinical Diagnostics with Xevo XR Innovation

BioMarin Partners n-Lorem on First ReNU Syndrome Therapy